Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
Titel:
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
Auteur:
Dragovich, T. Laheru, D. Dayyani, F. Bolejack, V. Smith, L. Seng, J. Burris, H. Rosen, P. Hidalgo, M. Ritch, P. Baker, A. F. Raghunand, N. Crowley, J. Hoff, D. D. Von